BMO Capital Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform

Article Related Articles (1) Stock Quotes (1) Comments (0)

BMO Capital downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Outperform to Market Perform with a price target of $37.00 (from $38.00).

For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.

Shares of Bristol-Myers Squibb Co. closed at $32.23 yesterday, with a 52 week range of $30.10-$36.34.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
• Janney Montgomery Scott Downgrades Cubist Pharmaceuticals (CBST) to Neutral
• TD Securities Downgrades Nordion Inc (NDZ) to Reduce

Create E-mail Alert Related Categories

Analyst PT Change, Downgrades

Related Entities

BMO Capital

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?